Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 09 - 20 tags : Drug save search
Verrica Pharmaceuticals Receives Complete Response Letter from the FDA identifying deficiencies at a facility of a Contract Manufacturer for its New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
Published: 2021-09-20 (Crawled : 22:00) - biospace.com/
VRCA | $6.85 0.88% 0.88% 86K
|
Health Technology
|
| O: -1.15%
H: 3.08%
C: 0.0%
molluscum new drug treatment fda contract drug
OneLegacy Foundation Funded UCLA Clinical Trial Successfully Completes Kidney Transplant Without Lifetime of Immunosuppressive Drugs
Published: 2021-09-20 (Crawled : 18:00) - biospace.com/
FNCTF | News | $11.16 -20.84% 130
|
Communications
| Email alert
Add to watchlist
trial drug kidney
Global Drug Delivery Partnering Deals Report/Directory 2021: Trends, Players and Financials 2014-2021
Published: 2021-09-20 (Crawled : 15:00) - prnewswire.com
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: -1.16%
H: 0.0%
C: 0.0%
drug drug delivery liver
Onconova Therapeutics Announces Upcoming Presentation at the 3rd Annual RAS Targeted Drug Development Summit
Published: 2021-09-20 (Crawled : 13:15) - globenewswire.com
ONTX | $0.9953 -5.61% 1.3M
|
Health Technology
|
| O: -4.11%
H: 2.04%
C: -3.67%
presentation drug
Blade Therapeutics Announces Positive Data from Preclinical Drug-Drug Interaction Study of Cudetaxestat, a Non-Competitive Autotaxin Inhibitor in Clinical Development for Idiopathic Pulmonary Fibrosis (IPF)
Published: 2021-09-20 (Crawled : 13:00) - biospace.com/
GLPG | News | $29.47 1.38% 1.36% 120K
|
Health Technology
|
| O: -2.97%
H: 2.56%
C: 1.65%
fibrosis positive drug preclinical cudetaxestat pre-clinical
Marinus Pharmaceuticals Announces FDA Acceptance for Filing and Priority Review of New Drug Application for Ganaxolone in CDKL5 Deficiency Disorder
Published: 2021-09-20 (Crawled : 12:15) - biospace.com/
MRNS | $1.455 -1.36% -1.37% 2.9M
|
Health Technology
|
| O: 3.32%
H: 4.57%
C: -0.59%
new drug fda fda acceptance drug application
Rhythm Pharmaceuticals Completes Submission of Supplemental New Drug Application to U.S. Food and Drug Administration for IMCIVREE®
Published: 2021-09-20 (Crawled : 12:15) - biospace.com/
RYTM A | $39.945 2.4% 2.34% 410K
|
Health Technology
|
| O: 2.11%
H: 1.03%
C: -3.44%
new drug food drug submission imcivree application
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for LAG-3-Blocking Antibody Relatlimab and Nivolumab Fixed-Dose Combination as Treatment for Patients with Unresectable or Metastatic Melanoma
Published: 2021-09-20 (Crawled : 12:00) - biospace.com/
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: 0.18%
H: 1.22%
C: -0.23%
food treatment antibody drug nivolumab
Aerie Pharmaceuticals Announces Appointment of Erik Pacyniak, Ph.D., D.A.B.T., as Director, Toxicology and Drug Disposition
Published: 2021-09-20 (Crawled : 12:00) - biospace.com/
AERI | $15.25 0.0%
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: 0.0%
drug
Matinas BioPharma Announces Accomplished Biotechnology Executive and Drug Developer Kathryn Penkus Corzo as Nominee to the Board of Directors
Published: 2021-09-20 (Crawled : 12:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -1.35%
H: 0.0%
C: 0.0%
MTNB | $0.1815 0.83% -0.61% 770K
|
Health Technology
|
| O: -4.27%
H: 1.79%
C: -1.79%
biopharma biotech drug technology iot
Rhythm Pharmaceuticals Completes Submission of Supplemental New Drug Application to U.S. Food and Drug Administration for IMCIVREE® (setmelanotide) for the treatment of obesity and control of hunger in Bardet-Biedl and Alström Syndromes
Published: 2021-09-20 (Crawled : 12:00) - globenewswire.com
RYTM A | $39.945 2.4% 2.34% 410K
|
Health Technology
|
| O: 2.11%
H: 1.03%
C: -3.44%
new drug food treatment obesity drug submission setmelanotide imcivree syndros
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.